Cell therapy weekly: FDA issues strong warning, diabetes gene therapy shows promise in mice, the Cell and Gene Therapy Catapult unveils new project and Takeda eyes an acquisition
In this new weekly column, Editor Freya Leask rounds up her news highlights from the last 7 days.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>